195 related articles for article (PubMed ID: 37894763)
21. [MicroRNA Expression Profiling of Diffuse Large B-Cell Lymphoma].
Veryaskina YA; Titov SE; Kovynev IB; Fyodorova SS; Shebunyaeva YY; Antonenko OV; Pospelova TI; Zhimulev IF
Mol Biol (Mosk); 2023; 57(3):492-500. PubMed ID: 37326052
[TBL] [Abstract][Full Text] [Related]
22. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
23. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
24. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
Roehle A; Hoefig KP; Repsilber D; Thorns C; Ziepert M; Wesche KO; Thiere M; Loeffler M; Klapper W; Pfreundschuh M; Matolcsy A; Bernd HW; Reiniger L; Merz H; Feller AC
Br J Haematol; 2008 Sep; 142(5):732-44. PubMed ID: 18537969
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma.
Shahid R; Gulzar R; Avesi L; Hassan S; Danish F; Mirza T
J Coll Physicians Surg Pak; 2016 Feb; 26(2):103-7. PubMed ID: 26876395
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
29. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the bone marrow by non-Hodgkin's lymphomas: incidence, histology and pathologic correlations.
Baroni CD; Manente L; Occhionero M; Marzullo A; Mandelli F; Biagini C
Tumori; 1981; 67(3):191-6. PubMed ID: 7025400
[TBL] [Abstract][Full Text] [Related]
31. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
Harris NL
Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
[TBL] [Abstract][Full Text] [Related]
32. [Lymphomas].
Lohri A
Praxis (Bern 1994); 2016 Jan; 105(1):47-52. PubMed ID: 26732717
[TBL] [Abstract][Full Text] [Related]
33. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-MartÃnez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
34. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
[TBL] [Abstract][Full Text] [Related]
35. Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.
Salles G; Gopal AK; Minnema MC; Wakamiya K; Feng H; Schecter JM; Wang M
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):275-284. PubMed ID: 30795996
[TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
Andhavarapu S; Crozier JA; Jiang L; Sher T
Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
[TBL] [Abstract][Full Text] [Related]
37. [Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas].
Klapper W; Wacker HH
Pathologe; 2007 Feb; 28(1):21-8. PubMed ID: 17195041
[TBL] [Abstract][Full Text] [Related]
38. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
[TBL] [Abstract][Full Text] [Related]
39. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
[TBL] [Abstract][Full Text] [Related]
40. An Atypical relapsing follicular lymphoma to composite Hodgkin's lymphoma.
Abadir S; Iska S; Bunting ST; Fu CL
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
